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Prebreeding Immunization of Beef Cows
Abstract
A number of infectious agents are potential threats to the fetus of a pregnant cow and may result in abortion.
These agents include Leptospira sp., Campylobacter fetus and viruses such as infectious bovine rhinotracheitis
(IBR) and bovine virus diarrhea (BVD). Maintenance in the cow of a high level of immunity to these agents
during pregnancy can insure protection of the fetus. In particular, vaccines against BVD and IBR viruses can
establish protective immunity throughout gestation. An appropriate vaccination regimen prior to breeding is
required to establish this protective immunity. This can be achieved with a single dose of certain modified live
virus vaccines, but those vaccines must be administered at least 30 days prior to breeding to avoid interference
with conception. We have evaluated an oil-adjuvanted inactivated virus vaccine in cattle with differing
immunological histories. Two doses of the vaccine administered 30 days apart to serologically negative
animals induced appreciable levels of BVD and IBR anti-viral antibodies with persisting titers throughout
gestation. In other experiments a single dose of the vaccine was administered to: (1) animals given two doses
of the vaccine several months earlier, (2) animals previously vaccinated with other inactivated virus vaccines,
or (3) animals previously vaccinated with modified live virus vaccine. The vaccine consistently induced
marked anamnestic responses in these animals. Not only did mean titers rise, but a vast majority of individual
animals responded. This contrasts with efforts to boost titers with modified live virus vaccines where the effect
may be erratic among animals. The safety and efficacy of selected inactivated viral vaccines argues for their use
in prebreeding immunization of beef cows.
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Summary
A number of infectious agents are potential threats to
the fetus of a pregnant cow and may result in abortion.
These agents include Leptospira sp., Campylobacter fetus
and viruses such as infectious bovine rhinotracheitis
(IBR) and bovine virus diarrhea (BVD).  Maintenance in
the cow of a high level of immunity to these agents
during pregnancy can insure protection of the fetus.  In
particular, vaccines against BVD and IBR viruses can
establish protective immunity throughout gestation.
An appropriate vaccination regimen prior to breeding is
required to establish this protective immunity.  This can
be achieved with a single dose of certain modified live
virus vaccines, but those vaccines must be administered
at least 30 days prior to breeding to avoid interference
with conception.  We have evaluated an oil-adjuvanted
inactivated virus vaccine in cattle with differing
immunological histories.  Two doses of the vaccine
administered 30 days apart to serologically negative
animals induced appreciable levels of BVD and IBR
anti-viral antibodies with persisting titers throughout
gestation.  In other experiments a single dose of the
vaccine was administered to:  (1) animals given two
doses of the vaccine several months earlier, (2) animals
previously vaccinated with other inactivated virus
vaccines, or (3) animals previously vaccinated with
modified live virus vaccine.  The vaccine consistently
induced marked anamnestic responses in these animals.
Not only did mean titers rise, but a vast majority of
individual animals responded.  This contrasts with
efforts to boost titers with modified live virus vaccines
where the effect may be erratic among animals.  The
safety and efficacy of selected inactivated viral vaccines
argues for their use in prebreeding immunization of beef
cows.
Introduction
A number of infectious agents are potential threats to
the fetus of a pregnant cow, often resulting in congenital
defects or abortion.  These agents include Leptospira sp.,
Campylobacter fetus and viruses such as infectious bovine
rhinotracheitis (IBR) and bovine virus diarrhea (BVD).
Maintenance in the cow of a high level of immunity to these
agents during pregnancy can insure protection of the fetus.
In particular, vaccines against BVD and IBR viruses can
establish protective immunity throughout gestation.  This
immunity can have at least three important effects: (1) to
enhance reproductive performance, (2) to protect the fetus
during gestation and (3) to increase availability of colostral
antibodies to the newborn calf.
Immunization can be an important component of
management practices.  However, there are reports that
vaccination does not always prevent viral effects on the
fetus.  This failure may be due in part to the use of vaccines
or a vaccine protocol that does not maintain a protective
level of immunity throughout gestation.  Such a situation
might be indicated by the observed level of antibodies in the
sera of two-year-old cows vaccinated at 6-7 months of age
with modified live virus vaccine (Table 1).
Table 1. Distribution of antibody titers among 83 two-
year-old cows vaccinated at 6-7 months of age with
modified live virus vaccine.
Number of Sera
Titer BVD-1 BVD-2 IBR
<2 0 8 16
2 0 14 9
4 4 20 14
8 4 9 22
16 13 10 13
32 9 8 8
64 21 10 1
128 10 3 0
252 7 0 0
812 10 0 0
1024 2 0 0
2048 2 0 0
4096 1 0 0
It should be noted that there was extreme variability in
antibody titers among the animals. A few animals had quite
high titers, but there were many with minimal titers against
the three viruses.  One could assume that the latter are
susceptible to viral infection.  We report the results of
experimentation utilizing several different viral vaccines for
the immunization of cows.
Materials and Methods
Animals utilized in this experimentation were crossbred
or Angus females resident at either the McNay or Rhodes
research farms.  Crossbred animals were raised on the farms.
The Angus were purchased when approximately eight
months of age and had a vaccination history.
The animals were bled and vaccinated as indicated in
the individual experiments.  All vaccines were purchased
from commercial sources and included:
A. Bovishield, Pfizer.  Modified live IBR and BVD
viruses,
B. Vira Shield, Grand Laboratories.  Inactivated viruses,
C. Cattlemaster 4, Pfizer.  Modified live IBR and
inactivated BVD viruses,
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D. Elite 4, Boehringer Ingleheim.  Inactivated viruses,
E. Triangle, Fort Dodge Laboratories.  Inactivated viruses,
and
F. Premier, Tech America.  Inactivated viruses.
Vaccines were administered according to the
manufacturers' recommendations.  Sera were harvested and
stored at –20oC until tested for antibodies with virus
neutralization tests.
Results
A series of experiments were conducted and are
reported as individual experiments with protocol and
findings.
Experiment I.  The 83 two-year-old cows included in
Table 1 were randomly assigned to one of three groups with
one group vaccinated with modified live virus vaccine (A),
another group with an inactivated virus vaccine (B) and the
third group left as unvaccinated controls.  Sera obtained
from these animals 19 days later were tested for antibodies
to BVD and IBR viruses.  Mean antibody titers increased
dramatically in vaccinated groups of cows (Table 2).
Table 2. Serum antibody titers of vaccinated and non-
vaccinated cows 19 days following administration of
modified live or inactivated virus vaccines.
                    Serum Antibody Levels
Group BVD-1 BVD-2 IBR
Control
Mean Titer* 45.9* 8.8 6.9
Range 4-4096 <2-2048 <2-32
MLV Vac**
Mean Titer 233.9 32.7 43.1
Range 16-2048 4-512 8-256
OIV Vac***
Mean Titer 362.0 54.7 30.5
Range 16-4096 16-1024 8-128
*     Reciprocal of neutralizing dilution
**   Modified live virus vaccine (A)
***Oil adjuvanted inactivated virus (B)
However, when responses of individual animals were
reviewed, cows with minimal BVD antibody titers at the
time of vaccination responded well to the inactivated virus
vaccine with more restricted enhancement in animals with a
high level of antibodies.  The responses of animals receiving
the modified live virus vaccine were more erratic with
minimal responses resulting in some animals with low titers
at the time of vaccination.
Experiment II.  Forty-two Angus heifers that had a
history of vaccination with modified live virus vaccine (A)
at 6-7 months of age were bled at one year of age.  BVD
virus neutralization tests indicated that all animals were
serologically positive.  The animals were vaccinated with an
inactivated virus vaccine (B), and the animals were bled for
serum 21 days later and again one year later.  Antibody
levels are provided in Table 3.
Table 3. Serum antibody levels in cows (21 days, and one
year following vaccination) with an oil-adjuvanted
inactivated virus vaccine (B).
   Serum Antibody Levels
Time BVD-1 BVD-2 IBR
Prevaccination
Mean Titer* 46.7* 12.8 1.4
Range 4-512 <2-256 <2-8
Postvaccination (21 days)
Mean Titer 3104.2 494.6 106.2
Range 128-4096 2-4096 4-256
Postvaccination (one year)
Mean Titer 252.5 63.1 19.0
Range 16-2048 16-512 4-128
*Reciprocal of neutralizing dilution
Marked increases in antibody titers were present at 21
days, and there was persistence of moderate levels of
antibodies for one year.  The distribution of titers among
individual animals is shown in Figure 1 and indicates the
relative uniformity of BVD antibody titers in these
vaccinated animals.
Figure 1. Frequency distribution of antibody titers in
sera of 40 two-year-old cows.  These animals were
vaccinated with modified live BVD virus vaccine (A) at
6-7 months of age and with inactivated virus vaccine (B)
at one year of age.
Experiment III.  Twenty head of heifer calves were
vaccinated twice with a 30-day interval with a modified live
IBR- inactivated BVD virus vaccine (C) at 5-6 months of
age.  These animals were bled and administered a booster
dose of inactivated virus vaccine when 13 months of age.
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They were bled again for serum three weeks later.
Frequency distribution of antibody titers in individual
animals against IBR, BVD-type 1 and BVD-type 2 viruses
are shown in Figures 2, 3 and 4.
Figure 2. Frequency distribution of IBR virus antibody
titers among 20 animals before and after secondary
vaccination with an inactivated virus vaccine (B).
Figure 3. Frequency distribution of BVD type 1 virus
antibody titers among 20 animals before and after
secondary vaccination with an inactivated virus vaccine
(B).
Figure 4. Frequency distribution of BVD type 2 virus
antibody titers among 20 animals before and after
secondary vaccination with an inactivated virus vaccine
(B).
Experiment IV.  Ninety-four heifer calves were
vaccinated intranasally with a modified live IBR virus
vaccine followed by two doses of inactivated IBR-BVD
virus vaccine (D or E) with a 30-day interval.  As yearlings,
they were bled, vaccinated with an inactivated virus vaccine
(B), and bled again three weeks later.  Prevaccination and
postvaccination antibody titers are provided in Table 4.
Table 4. Antibody responses of yearling heifers 21 days
after booster vaccination with an inactivated virus
vaccine (B).
Serum Antibody Levels
Time BVD-1 BVD-2 IBR
Prevaccination
Mean Titer* 3.3* 1.3 1.5
Range <2-64 <2-4 <2-8
Postvaccination
Mean Titer 278.2 16.3 40.8
Range <2-4096 <2-256 4-256
*Reciprocal of neutralizing dilution
Experiment V.  One hundred thirty yearling heifers that
had not been previously vaccinated with BVD virus and
were serologically negative were randomly assigned to one
of four groups.  The groups of animals were treated as
follows:  (1) Controls, no vaccination, (2) Vaccine B, (3)
Vaccine E, and (4) Vaccine F.  All vaccines were
administered according to the manufacturers' directions with
two vaccinations 30 days apart.  The heifers were bled 60
days after primary immunization, bled and boosted with the
same vaccine a year later, and bled again at the two-year
point.  Antibody levels to BVD virus are presented in Table
5.
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Table 5. BVD antibody levels at intervals over a two-
year period in cattle vaccinated with inactivated virus
vaccines.  Animals were vaccinated at 12, 13, and 26
months of age.
Serum BVD Virus Antibody Levels
       Age                Controls       Vaccine B   Vaccine E    Vaccine F
12 Months
No. 27 32 39 32
Mean Titer <2* <2 <2 <2
14 Months
No. 27 32 39 32
No. Positive 0 32 39 32
Mean Titer <2 635 286 185
26 Months
No. 25 28 34 23
No. Positive 2 28 34 21
Mean Titer 6** 55 27 10**
38 Months
No. 16 15 19 12
No. Positive 1 15 19 12
Mean Titer 16 234 89 26
*  Reciprocal of neutralizing dilution
**Positive animals only
The number of animals declined over the period of
experimentation due to culling.  However, the results clearly
demonstrated that Vaccine B would maintain good levels of
BVD antibodies in these animals when administered on an
annual basis.
Discussion
Protection of the bovine fetus from infection with IBR
and BVD viruses is dependent on the maintenance of a
minimum level of immunity in the cow.  The question that
arises is whether or not this immunity can be maintained
throughout gestation with selected vaccines and vaccination
protocol.  Results of serologic testing of cattle indicated that
levels of antibodies are markedly variant depending on the
type of vaccine utilized and the time of administration.  The
findings also confirm the need for annual vaccination of
cows in a breeding herd.  We suggest that this vaccination
be administered two to four weeks prior to breeding so that
strong immunity is present in these animals early in the
gestation period.  If modified live virus vaccines are used a
four-week interval is recommended due to the recognized
ability of the viruses to infect the ovary and interfere with
conception.
The findings of this experimentation support the usage
of an oil adjuvanted inactivated virus vaccine  (B).  This
vaccine:  (1) will induce good humoral responses in naïve
animals when two doses are administered 30 days apart, (2)
will induce excellent secondary responses in animals
previously primed with modified live or inactivated virus
vaccines, (3) will broaden the response to BVD viruses
because it contains both type 1 and type 2 viruses, and (4)
because the viruses are inactivated, can be safely utilized at
any time.
Acknowledgment
This experimentation was supported in part by funding
from the Iowa Livestock Health Advisory Council.
